These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38574400)

  • 1. Distinct spatial contributions of amyloid pathology and cerebral small vessel disease to hippocampal morphology.
    Xhima K; Ottoy J; Gibson E; Zukotynski K; Scott C; Feliciano GJ; Adamo S; Kuo PH; Borrie MJ; Chertkow H; Frayne R; Laforce R; Noseworthy MD; Prato FS; Sahlas DJ; Smith EE; Sossi V; Thiel A; Soucy JP; Tardif JC; Goubran M; Black SE; Ramirez J;
    Alzheimers Dement; 2024 May; 20(5):3687-3695. PubMed ID: 38574400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memory decline in elderly with cerebral small vessel disease explained by temporal interactions between white matter hyperintensities and hippocampal atrophy.
    van Leijsen EMC; Tay J; van Uden IWM; Kooijmans ECM; Bergkamp MI; van der Holst HM; Ghafoorian M; Platel B; Norris DG; Kessels RPC; Markus HS; Tuladhar AM; de Leeuw FE
    Hippocampus; 2019 Jun; 29(6):500-510. PubMed ID: 30307080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β.
    Freeze WM; Jacobs HI; Gronenschild EH; Jansen JF; Burgmans S; Aalten P; Clerx L; Vos SJ; van Buchem MA; Barkhof F; van der Flier WM; Verbeek MM; Rikkert MO; Backes WH; Verhey FR;
    J Alzheimers Dis; 2017; 55(1):333-342. PubMed ID: 27662299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET.
    Ottoy J; Ozzoude M; Zukotynski K; Adamo S; Scott C; Gaudet V; Ramirez J; Swardfager W; Cogo-Moreira H; Lam B; Bhan A; Mojiri P; Kang MS; Rabin JS; Kiss A; Strother S; Bocti C; Borrie M; Chertkow H; Frayne R; Hsiung R; Laforce RJ; Noseworthy MD; Prato FS; Sahlas DJ; Smith EE; Kuo PH; Sossi V; Thiel A; Soucy JP; Tardif JC; Black SE; Goubran M;
    Alzheimers Dement; 2023 Apr; 19(4):1503-1517. PubMed ID: 36047604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Pre-Clinical AD Small Vessel Disease is Associated With Altered Hippocampal Connectivity and Atrophy.
    Wu M; Schweitzer N; Iordanova BE; Halligan-Eddy E; Tudorascu DL; Mathis CA; Lopresti BJ; Kamboh MI; Cohen AD; Snitz BE; Klunk WE; Aizenstein HJ
    Am J Geriatr Psychiatry; 2023 Feb; 31(2):112-123. PubMed ID: 36274019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Determines Cognitive Functioning in the Oldest-Old? The EMIF-AD 90+ Study.
    Legdeur N; Badissi M; Yaqub M; Beker N; Sudre CH; Ten Kate M; Gordon MF; Novak G; Barkhof F; van Berckel BNM; Holstege H; Muller M; Scheltens P; Maier AB; Visser PJ
    J Gerontol B Psychol Sci Soc Sci; 2021 Sep; 76(8):1499-1511. PubMed ID: 32898275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Alzheimer's Disease Pathology and Small Vessel Disease With Cerebral White Matter Degeneration: A Tract-Based MR Diffusion Imaging Study.
    Li K; Wang S; Luo X; Zeng Q; Liu X; Hong L; Li J; Hong H; Xu X; Zhang Y; Jiaerken Y; Zhang R; Xie L; Xu S; Zhang X; Chen Y; Liu Z; Zhang M; Huang P
    J Magn Reson Imaging; 2024 Jul; 60(1):268-278. PubMed ID: 37737474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Data-Driven White Matter Hyperintensity Spatial Signatures With Distinct Cerebral Small Vessel Disease Etiologies.
    Phuah CL; Chen Y; Strain JF; Yechoor N; Laurido-Soto OJ; Ances BM; Lee JM;
    Neurology; 2022 Dec; 99(23):e2535-e2547. PubMed ID: 36123127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking white matter hyperintensities to regional cortical thinning, amyloid deposition, and synaptic density loss in Alzheimer's disease.
    Zhang J; Chen H; Wang J; Huang Q; Xu X; Wang W; Xu W; Guan Y; Liu J; Wardlaw JM; Deng Y; Xie F; Li B
    Alzheimers Dement; 2024 Jun; 20(6):3931-3942. PubMed ID: 38648354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal subregional volume changes in elders classified using positron emission tomography-based Alzheimer's biomarkers of β-amyloid deposition and neurodegeneration.
    Busatto Filho G; Duran FLS; Squarzoni P; Coutinho AMN; Rosa PGP; Torralbo L; Pachi CGDF; da Costa NA; Porto FHG; Carvalho CL; Brucki SMD; Nitrini R; Forlenza OV; Leite CDC; Buchpiguel CA; de Paula Faria D
    J Neurosci Res; 2021 Feb; 99(2):481-501. PubMed ID: 33073383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
    Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
    Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of White Matter Hyperintensities on Baseline and Longitudinal Amyloid-β in Cognitively Normal Individuals.
    Wong FCC; Saffari SE; Yatawara C; Ng KP; Kandiah N;
    J Alzheimers Dis; 2021; 84(1):91-101. PubMed ID: 34511497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.
    Cha WJ; Yi D; Ahn H; Byun MS; Chang YY; Choi JM; Kim K; Choi H; Jung G; Kang KM; Sohn CH; Lee YS; Kim YK; Lee DY
    Alzheimers Res Ther; 2024 Mar; 16(1):50. PubMed ID: 38454444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical tau load is associated with white matter hyperintensities.
    McAleese KE; Firbank M; Dey M; Colloby SJ; Walker L; Johnson M; Beverley JR; Taylor JP; Thomas AJ; O'Brien JT; Attems J
    Acta Neuropathol Commun; 2015 Sep; 3():60. PubMed ID: 26419828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral Small Vessel Disease Influences Hippocampal Subfield Atrophy in Mild Cognitive Impairment.
    Wong FCC; Yatawara C; Low A; Foo H; Wong BYX; Lim L; Wang B; Kumar D; Ng KP; Kandiah N
    Transl Stroke Res; 2021 Apr; 12(2):284-292. PubMed ID: 32894401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.
    Newton P; Tchounguen J; Pettigrew C; Lim C; Lin Z; Lu H; Moghekar A; Albert M; Soldan A;
    J Alzheimers Dis; 2023; 92(1):323-339. PubMed ID: 36744337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer's disease.
    Gaubert M; Lange C; Garnier-Crussard A; Köbe T; Bougacha S; Gonneaud J; de Flores R; Tomadesso C; Mézenge F; Landeau B; de la Sayette V; Chételat G; Wirth M
    Alzheimers Res Ther; 2021 Jan; 13(1):29. PubMed ID: 33461618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion imaging in dementia with Lewy bodies: Associations with amyloid burden, atrophy, vascular factors and clinical features.
    Donaghy PC; Firbank M; Petrides G; Lloyd J; Barnett N; Olsen K; Thomas AJ; O'Brien JT
    Parkinsonism Relat Disord; 2020 Sep; 78():109-115. PubMed ID: 32814228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Aβ (Amyloid-β) Levels and Severity and Progression of Small Vessel Disease.
    van Leijsen EMC; Kuiperij HB; Kersten I; Bergkamp MI; van Uden IWM; Vanderstichele H; Stoops E; Claassen JAHR; van Dijk EJ; de Leeuw FE; Verbeek MM
    Stroke; 2018 Apr; 49(4):884-890. PubMed ID: 29540613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.
    Guzman VA; Carmichael OT; Schwarz C; Tosto G; Zimmerman ME; Brickman AM;
    Alzheimers Dement; 2013 Oct; 9(5 Suppl):S124-31. PubMed ID: 23375566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.